The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(4-(cyclohexylmethoxy)-5-fluoro-2-methoxybenzyl)pyrrolidine-2-carboxamide ID: ALA1093699
PubChem CID: 46884138
Max Phase: Preclinical
Molecular Formula: C20H29FN2O3
Molecular Weight: 364.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OCC2CCCCC2)c(F)cc1CNC(=O)[C@@H]1CCCN1
Standard InChI: InChI=1S/C20H29FN2O3/c1-25-18-11-19(26-13-14-6-3-2-4-7-14)16(21)10-15(18)12-23-20(24)17-8-5-9-22-17/h10-11,14,17,22H,2-9,12-13H2,1H3,(H,23,24)/t17-/m0/s1
Standard InChI Key: XVMROVYEPAQHAE-KRWDZBQOSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
10.2319 -20.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2307 -21.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9456 -21.9527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6620 -21.5394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6591 -20.7088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9438 -20.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3721 -20.2936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0881 -20.7034 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8010 -20.2883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5167 -20.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7979 -19.4633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4950 -21.5224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2718 -21.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7761 -21.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3109 -20.4660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5173 -20.3001 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.5159 -21.9518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8018 -21.5387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0870 -21.9506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3756 -21.5322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6630 -21.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6581 -22.7660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3721 -23.1813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0910 -22.7712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3771 -21.9507 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3784 -22.7757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
5 7 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 10 1 0
3 4 2 0
1 16 1 0
7 8 1 0
2 17 1 0
17 18 1 0
8 9 1 0
18 19 1 0
19 20 1 0
4 5 1 0
10 9 1 1
2 3 1 0
9 11 2 0
10 12 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
5 6 2 0
4 25 1 0
6 1 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.46Molecular Weight (Monoisotopic): 364.2162AlogP: 3.16#Rotatable Bonds: 7Polar Surface Area: 59.59Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.70CX Basic pKa: 9.80CX LogP: 2.99CX LogD: 0.64Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.78Np Likeness Score: -0.78
References 1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB.. (2010) Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity., 20 (7): [PMID:20202843 ] [10.1016/j.bmcl.2010.01.107 ]